Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Cancer Chemotherapy and Pharmacology|November 12, 2009
Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancerMohammad H Pourgholami, Michael Szwajcer, Melvin Chin, et al.
British Journal of Clinical Pharmacology|May 21, 2020
Barriers and opportunities for the clinical implementation of therapeutic drug monitoring in oncologyBradley D Menz, Sophie L Stocker, Nick Verougstraete, et al.
Pain and Therapy|December 18, 2021
Pharmacokinetics, Safety, and Tolerability of a Medicinal Cannabis Formulation in Patients with Chronic Non-cancer Pain on Long-Term High Dose Opioid Analgesia: A Pilot StudyYvonne Bonomo, Amanda Norman, Lisa Collins, et al.
Cancer Chemotherapy and Pharmacology|December 6, 2005
A phase 1 and pharmacokinetic study of gemcitabine and oxaliplatin in patients with solid tumorsHui K Gan, Paul L Mitchell, Peter Galettis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Randomized crossover study evaluating the effect of gemcitabine infusion dose rate: evidence of auto-induction of gemcitabine accumulationPeter Grimison, Peter Galettis, Susan Manners, et al.
Asia-Pacific Journal of Clinical Oncology|February 22, 2011
The pharmacological advantage of prolonged dose rate gemcitabine is restricted to patients with variant alleles of cytidine deaminase c.79A>CEkkaphon Metharom, Peter Galettis, Susan Manners, et al.
British Journal of Clinical Pharmacology|June 29, 2018
Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effectsLaura M Dryburgh, Nanthi S Bolan, Christopher P L Grof, et al.
Cannabis and Cannabinoid Research|April 24, 2018
Prolonged Cannabidiol Treatment Effects on Hippocampal Subfield Volumes in Current Cannabis UsersCamilla Beale, Samantha J Broyd, Yann Chye, et al.
Proteomes|June 25, 2025
A Clinical Validation of a Diagnostic Test for Esophageal Adenocarcinoma Based on a Novel Serum Glycoprotein Biomarker Panel: PromarkerEsoJordana Sheahan, Iris Wang, Peter Galettis, et al.
Cancer Chemotherapy and Pharmacology|September 19, 2020
Ibudilast for prevention of oxaliplatin-induced acute neurotoxicity: a pilot study assessing preliminary efficacy, tolerability and pharmacokinetic interactions in patients with metastatic gastrointestinal cancerChristina Teng, Stephanie E Reuter, Prunella L Blinman, et al.
Pageof 6